Historical overview

Magnetism has been widely used across many scientific and industrial domains, including separation technologies, medical imaging, analytical chemistry, drug delivery, data processing, energy production, and transportation. For a long time, its main applications were limited to mining and metallurgy, particularly for the separation of iron ores. The first patent related to magnetic separation was filed in 1792 for iron mineral processing.

The application of magnetism in biotechnology is relatively recent. In the 1940s, magnetic iron oxides were introduced in wastewater treatment to remove dissolved and suspended biological materials. The development of high-gradient magnetic separation (HGMS) systems in the 1950s significantly improved the efficiency of magnetic particle recovery. However, it was only in the 1970s that selective magnetic adsorbents were developed, enabling the targeted isolation of valuable biomolecules. During this period, magnetic particles were also explored as supports for enzyme immobilization.

Today, magnetic separation is routinely applied in laboratories for the purification of cells, proteins, and nucleic acids, and is integrated into automated systems for high-throughput processing. Despite these advances, large-scale industrial implementation in biotechnology is still limited. Nevertheless, recent studies have demonstrated the potential of magnetic separation at preparative scale, such as the purification of monoclonal antibodies from large-volume cell cultures, highlighting reduced processing time as a key advantage.

Magnetic particles are not limited to separation applications. Scientific publications on magnetic beads and nanoparticles have increased significantly over the last two decades, reflecting growing interest in this field. In particular, magnetic nanoparticles have attracted strong attention due to their use in biomedical applications such as drug and gene delivery, imaging, tissue engineering, and magnetic hyperthermia. Several of these technologies are currently under clinical evaluation, and some products, including MRI contrast agents, are already commercially available.

Introduction

Magnetic separation provides a unique approach for the selective control and isolation of target biological components. Since most biological materials are non-magnetic, magnetic particles can be functionalized to specifically bind target molecules, enabling fast and selective separation under mild conditions with minimal mechanical stress.

This technique allows the purification of a wide range of biological structures, including intact cells, organelles, cell compartments, and large protein complexes. The efficiency of magnetic separation depends on the magnetic force applied to the particles, which must overcome diffusion, viscous drag, gravity, and other opposing forces.

The magnetic force acting on a particle is influenced by its volume, magnetic properties, and the applied magnetic field. In practice, two main types of systems are used:

• Low-gradient magnetic separators, based on permanent magnets, are suitable for small-scale applications and larger particles.

• High-gradient magnetic separation (HGMS) systems are required for small or weakly magnetic particles and for processing large volumes. These systems use strong magnetic fields and ferromagnetic matrices to generate high magnetic gradients, enabling efficient particle capture in flow conditions.

HGMS remains the most suitable option for large-scale bioprocessing, although industrial-scale systems are still under development. Unlike mining applications, biotechnological systems must meet strict requirements such as sterility, containment, and resistance to cleaning procedures.

Magnetic separation can be applied either for removing unwanted contaminants or for recovering a desired product. In the latter case, selective magnetic adsorbents are required. These particles can be functionalized with various ligands, including affinity, ion exchange, hydrophobic, or mixed-mode groups, similar to chromatographic materials. Additionally, pre-activated particles with reactive chemical groups allow flexible surface modification depending on the target application.

Magnetic properties

For most biotechnological applications, superparamagnetic particles with high magnetic responsiveness are preferred. These particles do not retain magnetization after removal of the magnetic field, which prevents aggregation and improves dispersion in solution. At the same time, they exhibit strong magnetic responses under an external field, enabling efficient separation.

Most magnetic particles are based on iron oxides such as magnetite (Fe₃O₄) and maghemite (γ-Fe₂O₃). At the nanoscale, these materials can exhibit superparamagnetic behavior, although their magnetic saturation may decrease compared to bulk materials. Other ferrite materials may offer higher magnetization but are generally less biocompatible and more sensitive to oxidation.

Biocompatibility is a key factor in biotechnology. Iron oxide particles, especially when coated with polymers such as dextran, have shown low toxicity and are widely used in biomedical applications.

Synthesis methods

The production of magnetic particles involves two main steps: synthesis of the magnetic core and surface modification.

 Synthesis of magnetic nanoparticles

Magnetic nanoparticles can be prepared using several methods, including coprecipitation, microemulsion, hydrothermal synthesis, thermolysis, and sol-gel processes. Among these, coprecipitation is the most commonly used due to its simplicity and scalability.

This method involves the precipitation of iron salts in alkaline conditions to form magnetite nanoparticles. The final properties of the particles depend on parameters such as pH, temperature, ionic strength, and reagent concentration.

Surface modification

Bare magnetic nanoparticles are unstable and prone to aggregation, with high non-specific interactions. Therefore, surface coating is essential to improve stability, reduce toxicity, and introduce functional groups for selective binding.

Coating materials include polymers, surfactants, silica, and small chelating molecules. These coatings enhance colloidal stability and allow further functionalization. For example:

• Polymers (e.g., dextran, chitosan, PEG) improve biocompatibility
• Surfactants stabilize particles in different media
• Silica coatings provide chemical stability and easy functionalization

Advanced polymerization techniques also enable precise control of particle structure and surface properties, improving performance in bioseparation processes.

Physical characteristics

The performance of magnetic particles is strongly influenced by their physical properties. Spherical particles are preferred due to better flow behavior and mechanical stability. Particle size and size distribution are also critical: smaller particles provide higher surface area and binding capacity, but require stronger magnetic fields for recovery.

A balance must be achieved between magnetic response and surface area. Ideally, particles should have a narrow size distribution to ensure consistent behavior. Porosity is another important factor, especially for small target molecules where non-porous particles help avoid diffusion limitations.

Ideal magnetic adsorbent

An optimal magnetic adsorbent for biotechnology should present the following characteristics:

• Superparamagnetic behavior with high magnetic susceptibility
• Uniform size distribution and spherical shape
• High binding capacity
• Low non-specific interactions
• Strong chemical and mechanical stability

 Cell separation

Magnetic separation is particularly suitable for cell isolation due to its fast and gentle conditions. Early studies demonstrated the separation of red blood cells based on their intrinsic magnetic properties. Later developments introduced magnetic particles functionalized with antibodies, enabling highly selective cell isolation.

Today, magnetic cell separation is widely used for both positive selection and depletion of specific cell populations. Target recognition is typically achieved using antibodies against cell surface markers, although other ligands such as lectins and small molecules can also be used.

Virus and virus-like particle separation

Magnetic particles are increasingly used in virology, mainly for detection and concentration of viruses. They allow efficient capture of viral particles while preserving their biological activity, which is often compromised in conventional methods. Although large-scale purification is still under development, magnetic separation shows strong potential in vaccine and gene therapy applications.

 Protein separation

Magnetic separation is an effective alternative to traditional chromatography for protein purification. It offers high binding capacity, rapid processing, and the ability to handle complex samples.

Different interaction modes can be used, including affinity, ion exchange, and hydrophobic interactions. This approach is particularly relevant for biopharmaceutical production, especially monoclonal antibodies, where magnetic adsorbents can reduce processing time and improve efficiency.

Nucleic acids

Magnetic particles are widely used for DNA and RNA purification due to their simplicity and efficiency. They allow direct processing of crude samples and eliminate the need for centrifugation and organic solvents.

Silica-coated magnetic particles are commonly used, exploiting selective binding of nucleic acids under specific salt conditions. This method is highly compatible with automation and high-throughput workflows.

 Process automation

Magnetic separation is easily automated due to the simplicity of magnetic manipulation. Many automated systems are available for nucleic acid, protein, and cell purification. These systems improve reproducibility, reduce processing time, and support high-throughput formats such as 96-well plates.

Conclusion 

Magnetic separation has become a powerful and versatile tool in biotechnology, particularly at laboratory scale. Its main advantages include fast processing, high selectivity, and compatibility with automation.

Although challenges remain for large-scale industrial applications, ongoing research and technological advancements are expected to overcome these limitations. Magnetic separation has strong potential to become a key alternative to conventional purification methods in bioprocessing.